About XIEYI Media
Since 2013, based on the "Highland of China's Novel drug thought", TONACEA has started to build a new media matrix, and has carried out multi-level reports on frontier technology, policies and regulations, capital markets, industrial transformation, innovative figures and other bio-innovation related fields. At present, TONACEA continues to serve more than 500 customers.
On wechat, TONACEA accounts have accumulated more than 300,000 subscribers, mainly including leaders of government, parks, listed companies, innovative pharmaceutical enterprises, investment institutions, and front-line practitioners. In addition, TONACEA has entered community platforms such as Snowball, Zhihu and Weibo. TONACEA's brand exposure has exceeded 24 million.
TONACEA
Hot Event Analysis
Subdivision Track Count
Interview of Industry Figures
Think Tank View Output
XIEYI Release
Enterprise Dynamics
Personnel Change
Product Progress
Policy Release
TONACEA Biotech
Interpretation of Frontier Achievements
Introduction to Basic Scientific Research
TONACEA Micro Service
Industrial Activity Information
Theme Live Preview
Recommendation
Bloomberg: Blocking Chinese new drugs, who is the United States protecting?
CPIC 2026 | Protheragen Session: Global Biomedical Cross-Border Transactions
Jointly explore sustainable and high-quality ways to expand globally.
Entering the 3.0 era of self exemption, Chinese pharmaceutical companies sit at the table
2026: Recovery, Breakthrough, and Gaming of Universal CAR-T
Contact us
Contribution and Writing articles
Yu Jing：15521120587
Media Release
Li Chun：19910611152
Contact us
Address：Room 305, Building 4, Zone 3, Hanwei International Plaza, Fengtai District, Beijing
Tel：010-83634390
Address：Address：Room 1704, Building E, Nanotechnology Park, SIP, Suzhou, Jiangsu Province
TONACEA
XIEYI Release
TONACEA Biotech
TONACEA Micro Service
©2025 TONACEA（beijing）Technology Development Co., Ltd
